Skip to main content
Log in

Comparison of the kinetics of methylene-diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Two 99mTc-labelled radio-diagnostics for bone scintigraphy, dicarboxypropan-diphosphonic acid (DPD) and methylene-diphosphonate (MDP) were compared. The test parameters were the time-activity curves of serum and of deproteinised serum, time-activity curves in regions of interest above the femur, the sacrum and the soft tissue medial of the femur, and the urinary excretion. The ratio of bone lesion to normal bone was compared for 6 h after the injection of each compound. The time-activity curves in the serum and the deproteinised serum were not very different, therefore the percentage of the radio-diagnostics bound to protein in blood were nearly the same. At 14 h post-injection nearly 80% of the activity remaining in the blood pool was bound to protein. The urinary excretion of MDP was 25% higher than that of DPD, because the renal clearance of DPD was 41% lower than that of MDP. The non-excreted activity was bound to bone; therefore in the regions of interest set above the sacrum, the femur and the soft tissue the activity ratio was 27% higher for DPD for the ratio os sacrum to soft tissue and 21% higher for the ratio femur to soft tissue, but there were similar results for both substances for the ratio bone lesion to normal bone; therefore MDP was not better than DPD in detecting bone lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Büll U, Pfeiffer JP, Niendorf HP, Tongendorff J, (1977) A computer assisted comparison of 99mTc-methylene-diphosphonate and 99mTc-pyrophosphate bone imaging. Br J Radiol 50:629–636

    Google Scholar 

  2. Ciba-Werke (1979) Wissenschaftliche Tabellen Geigy, Teilband Hämatologie und Humangenetik, 8. edition, Basel

  3. Kriegel H (1978) Radiopharmaka in der Skelettszintigraphie: Pharmakologie, Biokinetik und Strahlenbelastung. Der Nuklearmediziner 1, 6–11

    Google Scholar 

  4. Pauwels EKJ, Blom J, Camps JAJ, Hermans J, Rijke AM (1983) A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Eur J Nucl Med 8:118–122

    Google Scholar 

  5. Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD (1975) Technetium-99m-methylene-diphosphonate—a superior agent for skeletal imaging: Comparison with other technetium complexes. J Nucl Med 16:744–755

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schroth, HJ., Hausinger, F., Garth, H. et al. Comparison of the kinetics of methylene-diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy. Eur J Nucl Med 9, 529–532 (1984). https://doi.org/10.1007/BF00256849

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256849

Keywords

Navigation